Foot News and Research

RSS

Sinovac provides update on EV71 vaccine Phase III trial on HFMD

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, today provided an update on its Phase III clinical trial progress and commercialization preparation for its proprietary inactivated Enterovirus 71 (EV71) vaccine against hand, foot and mouth disease (HFMD).

26 Jun 2012

Clinical study to examine retrograde tibiopedal interventional approach for CLI

Clinical investigators are for the first time examining the retrograde tibiopedal interventional approach, an endovascular technique that has the potential to reduce the rate of leg amputations by as much as 50 percent in patients with critical limb ischemia (CLI), a manifestation of peripheral arterial disease (PAD).

26 Jun 2012

FDA approves Daiichi Sankyo's US-based Bethlehem packaging facility

Today, Daiichi Sankyo, Inc. received U.S. Food and Drug Administration (FDA) approval to package product at its first United States-based packaging facility located in Bethlehem, PA. With this approval, the Company expands its global supply chain capability, helping to ensure the supply of medicine to U.S. physicians and their patients.

25 Jun 2012

Health care system or patient-directed programs help prevent or manage diabetes

A new study has found that programs aimed at helping people prevent or manage diabetes are most successful if they are directed at the patient or the health care system. Programs aimed at physicians were only successful for patients with poorer diabetes control.

23 Jun 2012

Two-phalange fifth toe a ‘common variant’

UK research challenges common wisdom on the anatomy of the little toe, finding that over 40% of patients have two rather than three bones.

22 Jun 2012

Tips to keep kids safe while enjoying summer activities

Unintentional injuries are the number one cause of death in children in the United States. In fact, 2,000 children die each day from preventable injuries. With the summer months come an increased number of injuries.

20 Jun 2012

Study points to unexplored coding potential within the genome

Sequencing the human genome was just the first step. The next challenge is of the kind that makes history: to decode the genome, and understand how the information needed to construct a human being can be packaged into a single molecule.

19 Jun 2012

Rusk Rehabilitation moves to NYU Langone's new Ambulatory Care Center

NYU Langone Medical Center announced that Rusk Rehabilitation non-musculoskeletal outpatient rehabilitation care, research and administrative offices have moved to a 40,000 square-foot space in NYU Langone's new Ambulatory Care Center (ACC) located at 240 East 38th Street in Manhattan.

19 Jun 2012

Henry Schein Medical to distribute Alma Lasers' nail fungus treatment

Alma Lasers, Inc. has announced an exclusive distribution arrangement with Henry Schein Medical to launch its latest innovation Harmony ClearChoice – a new, fast, effective approach to nail restoration.

18 Jun 2012

Not many EHR systems meet new federal standards

Electronic health records (EHRs) are used widely by California physicians, but many of their systems are not designed to meet new federal standards aimed at improving the quality of health care, according to a report from UCSF researchers.

16 Jun 2012

Pain, appearance improvements satisfy foot and ankle surgery patients

Ongoing pain, appearance, choice of footwear, and impact of pain and function on social interaction are the main predictors for patient satisfaction following foot or ankle surgery, UK research indicates.

15 Jun 2012

CTC as accurate as conventional colonoscopy in detecting cancerous polyps

Computed tomographic colonography (CTC), also known as virtual colonoscopy, administered without laxatives is as accurate as conventional colonoscopy in detecting clinically significant, potentially cancerous polyps, according to a study performed jointly at the San Francisco VA Medical Center, the University of California, San Francisco and Massachusetts General Hospital.

15 Jun 2012

FDA clears KCI’s V.A.C.Therapy System

Kinetic Concepts, Inc. announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) to market its proprietary Vacuum Assisted Closure, or V.A.C. Therapy System, for the management of closed surgical incisions.

15 Jun 2012

FDA clears KFx Medical’s new tissue fixation anchor

KFx Medical Corporation announced it has received 510K clearance from the Food and Drug Administration (FDA) for its 5mm AppianFx Tissue Fixation Anchor.

15 Jun 2012

iWalk announces availability of BiOM bionic lower limb system for above-knee amputees

iWalk, the personal bionics company advancing technology to restore natural movement for lower-limb amputees, today announced the availability of its BiOM bionic lower limb system for above-knee amputees.

13 Jun 2012

Experimental drug and genetic differences indicate how people deal with fear and stress

Researchers at Duke University and the National Institutes of Health have found a way to calm the fears of anxious mice with a drug that alters their brain chemistry. They've also found that human genetic differences related to the same brain chemistry influence how well people cope with fear and stress.

12 Jun 2012

Vibrating device aids diabetic neuropathy foot screening

A small disposable vibrating device may help detect peripheral sensory neuropathy in patients with diabetes, say UK researchers who believe the gadget could replace tuning fork screening.

8 Jun 2012

Battle to control malaria in Cambodia 'not over'

"Two years after some $22 million in donor funds were pumped into malaria control along the Cambodia-Thailand border to fight off suspected resistance to treatment, health workers say the battle is not over," IRIN reports, adding, "The government reported 103,000 malaria infections and 151 deaths nationwide in 2010.

8 Jun 2012

UCSF's ACT program helps amputees reach their athletic goals

Carlos Gonzalez stands out from an athletic group gathered on a grassy field at the UCSF Mission Bay campus. The gregarious 32-year-old sports a stylish fauxhawk and walks with a confident yet understated swagger. He's training to become a mixed martial arts (MMA) fighter.

6 Jun 2012

Positive updated interim data from Exelixis’ cabozantinib phase 2 trial on CRPC

Exelixis, Inc. today reported positive updated interim data from an ongoing phase 2 trial of cabozantinib in men with metastatic castration-resistant prostate cancer (CRPC) and bone metastases.

6 Jun 2012